Skip to main content

Advertisement

Log in

Serum gastrin values in patients with familial adenomatous polyposis

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: An evaluation of the importance of gastrin in the colorectal carcinogenesis in patients with familial adenomatous polyposis was conducted. METHODS: Blood samples from 168 family members of 26 families were investigated for circulating gastrin. Blood was drawn from 65 affected patients, 66 clinically unaffected first-degree relatives, and 37 spouses. RESULTS: We did not find any difference in distribution of serum gastrin among these groups. CONCLUSION: Our results seem to exclude gastrin from being relevant in early carcinogenesis in patients with familial adenomatous polyposis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bülow S. Clinical features of familial polyposis coli: results of the Danish polyposis register. Dis Colon Rectum 1986;29:102–7.

    PubMed  Google Scholar 

  2. Groden J, Thilveris A, Samowitz W,et al. Identification and characterization of the familial adenomatous polyposis gene. Cell 1991;68:589–600.

    Google Scholar 

  3. Joslyn G, Carlson M, Thilveris A,et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991;68:601–13.

    Google Scholar 

  4. Bodmer WF, Bailey CJ, Bodmer J,et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614–6.

    PubMed  Google Scholar 

  5. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759–67.

    PubMed  Google Scholar 

  6. Stanbridge EJ. Identifying tumor suppressor genes in human colorectal cancer. Science 1990;247:12–3.

    PubMed  Google Scholar 

  7. Tahara E. Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol 1990;116:121–31.

    PubMed  Google Scholar 

  8. Karlin DA, Mcbath M, Jones RD, Elwyn KE, Romsdal MM. Hypergastrinæmi and colorectal carcinogenesis in the rat. Cancer Letters 1985;29:73–8.

    PubMed  Google Scholar 

  9. Winsett OE, Townsend CM, Glass EJ, Thompson JC. Gastrin stimulates growth of colon cancer. Surgery 1986;90:302–7.

    Google Scholar 

  10. Kusyk CJ, McNeil NO, Johnson LR. Stimulation of growth of a colon cancer cell line by gastrin. Am J Physiol 1986;251:G597–601.

    PubMed  Google Scholar 

  11. Palmer Smith J, Solomon TE. Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology 1988;95:1541–8.

    PubMed  Google Scholar 

  12. Watson S, Durrant L, Morris D. Gastrin: growth enhancing effets on human gastric and colonic tumour cells. Br J Cancer 1989;59:554–8.

    PubMed  Google Scholar 

  13. Palmer Smith J, Wood JG, Solomon TE. Elevated gastrin levels in patients with colon cancer or adenomatous polyps. Dig Dis Sci 1989;34:171–4.

    PubMed  Google Scholar 

  14. Wong K, Beardshall K, Waters CM, Calan J, Poston GJ. Postprandial hypergastrinæmi in patients with colorectal cancer. Gut 1991;32:1352–4.

    PubMed  Google Scholar 

  15. Charnley RM, Thomas WM, Stanley J, Morris DL. Serum gastrin concentrations in colorectal cancer patients. Ann R Coll Surg Engl 1992;74:138–41.

    PubMed  Google Scholar 

  16. Rehfeld JF, Stadil F, Rubin B. Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest 1972;30:221–32.

    PubMed  Google Scholar 

  17. Stadil F, Rehfeld JF. Preparation of125I-labelled synthetic human gastrin I for radioimmunoanalysis. Scand J Clin Lab Invest 1972;30:361–8.

    PubMed  Google Scholar 

  18. Rehfeld JF, Stadil F. Gelfiltration studies on immunopositive gastrin in serum from Zollinger-Ellison patients. Gut 1973;14:369–73.

    PubMed  Google Scholar 

  19. Rehfeld JF. Gastrins in serum. A review on gastrin radioimmunoaanalysis and the discovery of gastrin heterogeneity in serum. Scand J Gastroenterol 1973;8:577–83.

    PubMed  Google Scholar 

  20. Stadil F, Rehfeld JF. Determination of gastrin in serum. Scand J Gastroenterol 1973;8:101–12.

    PubMed  Google Scholar 

  21. Stadil F, Stage JG. Gastrinomas as model for duodenal ulcer disease. In: Rehfeld JF, Amdrup E, eds. Gastrins and the vagus. New York: Academic Press, 1979:199–210.

    Google Scholar 

  22. Suzuki H, Matsumoto K, Terashima H. Serum levels of gastrin in patients with colorectal neoplasia. Dis Colon Rectum 1988;31:716–7.

    PubMed  Google Scholar 

  23. Christensen KC, Stadil F, Malmstrøm J, Rehfeld JF. The effect of beta-adrenergic and cholinergic blockade on the circadian rhythm of gastrins in serum. Scand J Gastroenterol 1978;13:263–72.

    PubMed  Google Scholar 

  24. Goldschmiedt M, Barnett CC, Schwarts BE, Karnes WE, Redfern JS, Feldman M. Effect of age gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991;101:977–90.

    PubMed  Google Scholar 

  25. Upp JR, Singh P, Townsend CM, Thompson JC. Clinical significance of gastrin receptors in human colon cancer. Cancer Res 1989;49:488–92.

    PubMed  Google Scholar 

  26. Vogelstein B, Fearon ER, Kern SE,et al. Allelotype of colorectal cancer. Science 1989;244:207–11.

    PubMed  Google Scholar 

  27. Sunday ME, Kaplan LM, Motoyama E, Chin WW, Spindel ER. Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. Lab Invest 1988;59:5–24.

    PubMed  Google Scholar 

  28. Fearon ER, Cho KR, Nigro JM,et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990;247:49–56.

    PubMed  Google Scholar 

  29. Lund T, Geurts van Kessel AH, Haun S, Dixon JE. The genes for human gastrin and cholecystokinin are located on different chromosomes. Hum Genet 1986;73:77–80.

    PubMed  Google Scholar 

  30. Vogelstein B, Fearon ER, Hamilton SR,et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525–32.

    PubMed  Google Scholar 

  31. Luk GD, Baylin SB. Ornithine decarboxylase as a biological marker in familial colonic polyposis. N Engl J Med 1984;311:80–3.

    PubMed  Google Scholar 

  32. Pegg AE, McCann PP. Polyamin metabolism and function. Am J Physiol 1982;243:C212–21.

    PubMed  Google Scholar 

  33. Townsend CM, Beauchamp D, Thompson JC. Growth factors and intestinal neoplasms. Am J Surg 1988;155:526–36.

    PubMed  Google Scholar 

  34. Upp JR, Saydjari R, Townsend CM, Singh P, Barranco SC, Thompson JC. Polyamine levels and gastrin receptors in colon cancers. Ann Surg 1988;207:662–9.

    PubMed  Google Scholar 

  35. Arlow FL, Walczak SM, Moshier JA, Pietruk T, Majumdar AP. Gastrin and epidermal growth factor induction of ornithine decarboxylase in colonic explants. Life Sci 1990;46:777–84.

    PubMed  Google Scholar 

  36. Majumdar AP. Role of tyrosine kinase in gastrin induction of ornithine decarboxylase in colonic mucosa. Am J Physiol 1990;259:G6:26–30.

    Google Scholar 

  37. Koo HB, Sigurdson ER, Daly JM, Berenson M, Groshen S, Decosse JJ. Ornithine decarboxylase levels in the rectal mucosa of patients with colonic neoplasia. J Surg Oncol 1988;38:240–3.

    PubMed  Google Scholar 

  38. Hietala OA, Yum KY, Pilon J,et al. Proporties of ornithine decarboxylase in human colorectal adenocarcinomas. Cancer Res 1990;50:2088–94.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Svendsen, L.B., Bisgård, M.L., Gustafsen, J. et al. Serum gastrin values in patients with familial adenomatous polyposis. Dis Colon Rectum 37, 22–25 (1994). https://doi.org/10.1007/BF02047209

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02047209

Key words

Navigation